Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 15 | $172,281 |
Sells | 1 | $8,859 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
10 Apr 2024 20:38 | ONCT | Oncternal Therapeutics Inc | WILLS ROBERT JAMES | Director | 08 Apr 2024 | Purchase | 3,086 | 8.9613 | 27,655 | D |
01 Apr 2024 19:00 | ONCT | Oncternal Therapeutics Inc | WILLS ROBERT JAMES | Director | 28 Mar 2024 | Purchase | 6,914 | 8.4759 | 58,602 | D |
27 Feb 2024 17:03 | ONCT | Oncternal Therapeutics Inc | HALE DAVID F | Director | 23 Feb 2024 | Purchase | 266 | 9.04 | 2,405 | I |
27 Feb 2024 17:03 | ONCT | Oncternal Therapeutics Inc | HALE DAVID F | Director | 23 Feb 2024 | Purchase | 714 | 9.04 | 6,455 | D |
27 Feb 2024 17:02 | ONCT | Oncternal Therapeutics Inc | WILLS ROBERT JAMES | Director | 23 Feb 2024 | Sale | 980 | 9.04 | 8,859 | D |
14 Jun 2023 16:00 | ONCT | Oncternal Therapeutics Inc | KAUFMANN GUNNAR F. | Chief Scientific Officer | 14 Jun 2023 | Purchase | 3,000 | 0.3597 | 1,079 | D |
14 Jun 2023 16:00 | ONCT | Oncternal Therapeutics Inc | KAUFMANN GUNNAR F. | Chief Scientific Officer | 12 Jun 2023 | Purchase | 25,000 | 0.3498 | 8,745 | D |
17 Apr 2023 06:00 | ONCT | Oncternal Therapeutics Inc | BREITMEYER JAMES B | Chief Executive Officer | 14 Apr 2023 | Purchase | 2,250 | 0.29 | 652 | I |
17 Apr 2023 06:00 | ONCT | Oncternal Therapeutics Inc | BREITMEYER JAMES B | Chief Executive Officer | 14 Apr 2023 | Purchase | 47,750 | 0.299 | 14,277 | I |
17 Apr 2023 06:00 | ONCT | Oncternal Therapeutics Inc | BREITMEYER JAMES B | Chief Executive Officer | 13 Apr 2023 | Purchase | 100,000 | 0.29 | 29,000 | I |
14 Apr 2023 18:02 | ONCT | Oncternal Therapeutics Inc | YAZJI SALIM | Chief Medical Officer | 14 Apr 2023 | Purchase | 5,000 | 0.3 | 1,500 | D |
14 Apr 2023 18:02 | ONCT | Oncternal Therapeutics Inc | YAZJI SALIM | Chief Medical Officer | 13 Apr 2023 | Purchase | 10,000 | 0.285 | 2,850 | D |
14 Apr 2023 18:02 | ONCT | Oncternal Therapeutics Inc | YAZJI SALIM | Chief Medical Officer | 12 Apr 2023 | Purchase | 10,000 | 0.285 | 2,850 | D |
14 Apr 2023 06:00 | ONCT | Oncternal Therapeutics Inc | LEAVITT CHASE C. | General Counsel/Secretary | 13 Apr 2023 | Purchase | 10,000 | 0.29 | 2,900 | D |
14 Apr 2023 06:00 | ONCT | Oncternal Therapeutics Inc | LEAVITT CHASE C. | General Counsel/Secretary | 12 Apr 2023 | Purchase | 15,000 | 0.29 | 4,350 | D |
14 Apr 2023 06:00 | ONCT | Oncternal Therapeutics Inc | VINCENT RICHARD G | Chief Financial Officer | 13 Apr 2023 | Purchase | 30,000 | 0.2987 | 8,961 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)